Therapeutic effects of fibrates in postprandial lipemia (Q37239037)

19 August 2017

1 reference

title

Therapeutic effects of fibrates in postprandial lipemia (English)

1 reference

19 August 2017

1 reference

Genovefa D Kolovou

1

1 reference

19 August 2017

Peggy M Kostakou

series ordinal

2

1 reference

19 August 2017

Katherine K Anagnostopoulou

series ordinal

3

1 reference

19 August 2017

Dennis V Cokkinos

series ordinal

4

1 reference

19 August 2017

publication date

1 January 2008

1 reference

American journal of cardiovascular drugs

19 August 2017

published in

1 reference

19 August 2017

volume

8

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

243-255

1 reference

Atherogenesis: a postprandial phenomenon

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Biliary lipids, lithogenic index and biliary drug concentrations during etofibrate and bezafibrate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase, and the low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

Membrane Active Lipids in Remnant Lipoproteins Cause Impairment of Endothelium-Dependent Vasorelaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00129784-200808040-00004

10.2165/00129784-200808040-00004

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1006873550

0 references

1 reference